An open label, repeat dose, dose escalation study conducted in RLS [restless legs syndrome] patients to characterize pharmacokinetics and food effect of ropinirole controlled release for RLS.

Trial Profile

An open label, repeat dose, dose escalation study conducted in RLS [restless legs syndrome] patients to characterize pharmacokinetics and food effect of ropinirole controlled release for RLS.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Mar 2012

At a glance

  • Drugs Ropinirole (Primary)
  • Indications Restless legs syndrome
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 15 Oct 2008 Actual start date changed from Sep 2006 to Aug 2006 as reported by Clinicaltrials.gov
    • 12 Oct 2008 Trial phase changed from II to I as reported by ClinicalTrials.gov.
    • 04 Sep 2007 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top